Chlamydia pneumoniae: A suspected pathogenetic factor of coronary arteriosclerosis;Chlamydia pneumoniae - Ein vermuteter pathogenetischer faktor der koronararteriensklerose

Pathologe

Volumn 20, Issue 4, 1999, Pages 230-235

  Kunz, J ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANEURYSM; ATHEROGENESIS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; REVIEW;

CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS; VIRULENCE;

EID: 0032779396     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050350     Document Type: Review

References (30)

1. Blasi F, Denti F, Erba M et al. (1996) Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34:2766-2769
2. Boman J, Soderberg S, Forsberg et al. (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178(1):274-277
3. Boring L, Gosling J, Clearly M et al. (1998) Decreased lesion formation in CCR2-A mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897
4. Bräsen JH, Niendorf A (1997) Atherosklerose. Formale Pathogenese, Klassifikation und funktionelle Bedeutung. Pathologe 18:218-227
5. Campbell LA, O'Brien ER, Cappuccio AL et al. (1995) Detection of Chlamydia pneumoniae (TWAR) in human coronary artherectomy tissues. J Infect Dis 172:585-588
6. Dahlén GH, Boman J, Birgander LS et al. (1995) Lp (a) lipoprotein, IgG, IgA und IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114:165-174
7. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436
8. Fong IW, Chiu B, Viira E et al. (1997) Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35:48-52
9. Fuster V, Badimon L, Badimon JJ et al. (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250
10. Gaydos CA, Summersgill JT, Sahney NN et al. (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun 64:1614-1620
11. Gleichmann U, Gleichmann S (1998) Arteriosklerose - eine Infektion durch Chlamydia pneumoniae? Dtsch Med Wochenschr 123:98-99
12. Grayston JT (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect 167:841-849
13. Grayston JT (1998) Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events (editorial). Circulation 97:1669-1670
14. Grayston JT, Kuo C-C, Coulson As et al. (1995) Clamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92:3397-3400
15. Grayston JT, Kuo C-C, Campbell LA et al. (1997) Chlamydia pneumoniae and cardiovascular disease. Cardiologia 42:1145-1151
16. Gupta S, Leatham EW, Carrington D et al. (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407
17. Gurfinkel E, Bozovich G, Beck E et al. (1999) Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndroms. Eur Heart J 20:121-127
18. Jackson LA, Campbell LA, Schmidt RA et al. (1997) Specifity of detection of Chlamydia pneumoniae in cardiovascular atheroma-evaluation of the innocent bystander hypothesis. Am J Pathol 150:1785-1790
19. Juvonen J, Juvonen T, Laurila A et al. (1997) Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysm. J Vasc Surg 25:499-505
20. Kunz J (1995) Gefäße. In: Blümcke S (Hrsg) Pathologie. de Gruyter, Berlin New York, S 539-557
21. Kuo CC, Shor A, Campbell LA et al. (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-849
22. Kuo CC, Gown AM, Benditt EP et al. (1993) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13:1501-1504
23. Kuo CC, Grayston JT, Campbell LA et al. (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92:6911-6914
24. Kuo CC, Coulson AS, Campbell LA et al. (1997) Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 26:29-31
25. Laitinen K, Laurila A, Pyhälä I et al. (1997) Chlamydia pneumoniae infection induces Inflammatory Changes in the Aortas of Rabbits. Infect Immun 65:4832-4835
26. Leinonen M, Linnanmäki E, Mattila K et al. (1990) Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microbiol Pathol 9:67-73
27. Lendon CL, Davies MJ, Born GVR et al. (1991) Atherosclerotic plaques caps are locally weakened when macrophages density is increased. Atherosclerosis 87:87-90
28. Linnanmäki E, Leinonen M, Mattila K et al. (1993) Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 87:130-134
29. Marre R, Essig A (1997) Chlamydia pneumoniae and Atherosklerose. Dtsch Med Wochenschr 122:1092-1095
30. Mattila KJ, Valtonen VV, Nieminen MS et al. (1998) Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis26(3):719-734